{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:40:01Z","timestamp":1772757601494,"version":"3.50.1"},"reference-count":42,"publisher":"American Association for Cancer Research (AACR)","issue":"1","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,1,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>High-grade prostatic intraepithelial neoplasia (PIN) is the most likely precursor of prostate adenocarcinoma, but the frequency and timing of epigenetic changes found in prostate carcinogenesis has not been extensively documented. Thus, the promoters of three genes (APC, GSTP1, and RAR\u03b22) involved in prostate carcinogenesis were tested by quantitative methylation-specific PCR in tissue DNA from 30 prostate carcinomas, 128 high-grade PIN lesions, and 30 normal prostate tissue samples dissected from 30 radical prostatectomy specimens using laser capture microdissection. The percentage of methylated alleles (PMA) was calculated for each gene, and hierarchical cluster analysis was used to define the degree of similarity of epigenetic alterations among the various samples. We found that PMA values of APC and RAR\u03b22 were higher than those of GSTP1 in all three types of tissue samples and median PMA values for all three genes were higher in prostate cancer. By cluster analysis, 26 of 30 prostate carcinomas and 82 of 128 high-grade PIN lesions were grouped in the \u201chigh methylation\u201d branch, whereas 24 of 30 normal prostate tissue samples were allocated in the \u201clow methylation\u201d branch. Although high-grade PIN lesions are epigenetically more similar to prostate carcinoma than to normal prostate tissue, paired prostate carcinoma and high-grade PIN lesions did not always segregate together. We concluded that APC and RAR\u03b22 hypermethylation is frequent in normal prostate tissue and the progressive enrichment in cells carrying methylated alleles observed in high-grade PIN and prostate carcinoma is consistent with clonal progression. Because GSTP1 promoter methylation is mainly observed in prostate carcinoma and some high-grade PIN lesions, it represents an important marker for the transition of in situ to invasive neoplasia. (Mol Cancer Res 2006;4(1):1\u20138)<\/jats:p>","DOI":"10.1158\/1541-7786.mcr-05-0113","type":"journal-article","created":{"date-parts":[[2006,1,20]],"date-time":"2006-01-20T01:39:45Z","timestamp":1137721185000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Epigenetic Heterogeneity of High-Grade Prostatic Intraepithelial Neoplasia: Clues for Clonal Progression in Prostate Carcinogenesis"],"prefix":"10.1158","volume":"4","author":[{"given":"Rui","family":"Henrique","sequence":"first","affiliation":[{"name":"1Department of Otolaryngology-Head and Neck Surgery, Head and Neck Cancer Research Division, Johns Hopkins University School of Medicine, Baltimore, Maryland and Departments of"},{"name":"2Pathology,"},{"name":"5Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto; and"}]},{"given":"Carmen","family":"Jero\u0301nimo","sequence":"additional","affiliation":[{"name":"1Department of Otolaryngology-Head and Neck Surgery, Head and Neck Cancer Research Division, Johns Hopkins University School of Medicine, Baltimore, Maryland and Departments of"},{"name":"2Pathology,"},{"name":"3Genetics, and"},{"name":"6Fernando Pessoa University School of Health Sciences, Porto, Portugal"}]},{"given":"Manuel R.","family":"Teixeira","sequence":"additional","affiliation":[{"name":"3Genetics, and"},{"name":"5Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto; and"}]},{"given":"Mohammad O.","family":"Hoque","sequence":"additional","affiliation":[{"name":"1Department of Otolaryngology-Head and Neck Surgery, Head and Neck Cancer Research Division, Johns Hopkins University School of Medicine, Baltimore, Maryland and Departments of"}]},{"given":"Andre\u0301 L.","family":"Carvalho","sequence":"additional","affiliation":[{"name":"1Department of Otolaryngology-Head and Neck Surgery, Head and Neck Cancer Research Division, Johns Hopkins University School of Medicine, Baltimore, Maryland and Departments of"}]},{"given":"Irene","family":"Pais","sequence":"additional","affiliation":[{"name":"2Pathology,"}]},{"given":"Franclim R.","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"3Genetics, and"}]},{"given":"Jorge","family":"Oliveira","sequence":"additional","affiliation":[{"name":"4Urology, Portuguese Oncology Institute-Porto;"}]},{"given":"Carlos","family":"Lopes","sequence":"additional","affiliation":[{"name":"5Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto; and"}]},{"given":"David","family":"Sidransky","sequence":"additional","affiliation":[{"name":"1Department of Otolaryngology-Head and Neck Surgery, Head and Neck Cancer Research Division, Johns Hopkins University School of Medicine, Baltimore, Maryland and Departments of"}]}],"member":"1086","published-online":{"date-parts":[[2006,1,30]]},"reference":[{"key":"2024010416382181000_BIB1","doi-asserted-by":"crossref","unstructured":"Jemal A, Tiwari RC, Murray T, et al. American Cancer Society. Cancer statistics 2004. CA Cancer J Clin\u20082004;54:8\u201329.","DOI":"10.3322\/canjclin.54.1.8"},{"key":"2024010416382181000_BIB2","doi-asserted-by":"crossref","unstructured":"Montironi R, Mazzucchelli R, Scarpelli M. Precancerous lesions and conditions of the prostate: from morphological and biological characterization to chemoprevention. Ann N Y Acad Sci\u20082002;963:169\u201384.","DOI":"10.1111\/j.1749-6632.2002.tb04108.x"},{"key":"2024010416382181000_BIB3","doi-asserted-by":"crossref","unstructured":"Sakr WA, Haas GP, Cassin BF, Pontes JE, Crissman JD. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol\u20081993;150:379\u201385.","DOI":"10.1016\/S0022-5347(17)35487-3"},{"key":"2024010416382181000_BIB4","doi-asserted-by":"crossref","unstructured":"Bostwick DG, Montironi R, Sesterhenn IA. Diagnosis of prostatic intraepithelial neoplasia: Prostate Working Group\/consensus report. Scand J Urol Nephrol Suppl\u20082000;205:3\u201310.","DOI":"10.1080\/003655900750169266"},{"key":"2024010416382181000_BIB5","doi-asserted-by":"crossref","unstructured":"Montironi R, Mazzucchelli R, Stramazzotti D, Pomante R, Thompson D, Bartels PH. Expression of \u03c0-class glutathione S-transferase: two populations of high grade prostatic intraepithelial neoplasia with different relations to carcinoma. Mol Pathol\u20082000;53:122\u20138.","DOI":"10.1136\/mp.53.3.122"},{"key":"2024010416382181000_BIB6","unstructured":"Emmert-Buck MR, Vocke CD, Pozzatti RO, et al. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res\u20081995;55:2959\u201362."},{"key":"2024010416382181000_BIB7","unstructured":"Qian J, Bostwick DG, Takahashi S, et al. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res\u20081995;55:5408\u201314."},{"key":"2024010416382181000_BIB8","doi-asserted-by":"crossref","unstructured":"Haggman MJ, Wojno KJ, Pearsall CP, Macoska JA. Allelic loss of 8p sequences in prostatic intraepithelial neoplasia and carcinoma. Urology\u20081997;50:643\u20137.","DOI":"10.1016\/S0090-4295(97)00304-X"},{"key":"2024010416382181000_BIB9","doi-asserted-by":"crossref","unstructured":"Bostwick DG, Shan A, Qian J, et al. Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma. Cancer\u20081998;83:1995\u20132002.","DOI":"10.1002\/(SICI)1097-0142(19981101)83:9<1995::AID-CNCR16>3.0.CO;2-2"},{"key":"2024010416382181000_BIB10","doi-asserted-by":"crossref","unstructured":"Ruijter ET, Miller GJ, van de Kaa CA, et al. Molecular analysis of multifocal prostate cancer lesions. J Pathol\u20081999;188:271\u20137.","DOI":"10.1002\/(SICI)1096-9896(199907)188:3<271::AID-PATH359>3.0.CO;2-K"},{"key":"2024010416382181000_BIB11","doi-asserted-by":"crossref","unstructured":"Beheshti B, Vukovic B, Marrano P, Squire JA, Park PC. Resolution of genotypic heterogeneity in prostate tumors using polymerase chain reaction and comparative genomic hybridization on microdissected carcinoma and prostatic intraepithelial neoplasia foci. Cancer Genet Cytogenet\u20082002;137:15\u201322.","DOI":"10.1016\/S0165-4608(02)00540-X"},{"key":"2024010416382181000_BIB12","doi-asserted-by":"crossref","unstructured":"Bastacky S, Cieply K, Sherer C, Dhir R, Epstein JI. Use of interphase fluorescence in situ hybridization in prostate needle biopsy specimens with isolated high-grade prostatic intraepithelial neoplasia as a predictor of prostate adenocarcinoma on follow-up biopsy. Hum Pathol\u20082004;35:281\u20139.","DOI":"10.1016\/j.humpath.2003.10.019"},{"key":"2024010416382181000_BIB13","doi-asserted-by":"crossref","unstructured":"Ashida S, Nakagawa H, Katagiri T, et al. Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs. Cancer Res\u20082004;64:5963\u201372.","DOI":"10.1158\/0008-5472.CAN-04-0020"},{"key":"2024010416382181000_BIB14","doi-asserted-by":"crossref","unstructured":"Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med\u20082003;349:2042\u201354.","DOI":"10.1056\/NEJMra023075"},{"key":"2024010416382181000_BIB15","doi-asserted-by":"crossref","unstructured":"Jero\u0301nimo C, Usadel H, Henrique R, et al. Quantitation of GSTP1 hypermethylation distinguishes between non-neoplastic prostatic tissue and organ confined prostate adenocarcinoma. J Natl Cancer Inst\u20082001;93:1747\u201352.","DOI":"10.1093\/jnci\/93.22.1747"},{"key":"2024010416382181000_BIB16","unstructured":"Maruyama R, Toyooka S, Toyooka KO, et al. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin Cancer Res\u20082002;8:514\u20139."},{"key":"2024010416382181000_BIB17","doi-asserted-by":"crossref","unstructured":"Yamanaka M, Watanabe M, Yamada Y, et al. Altered methylation of multiple genes in carcinogenesis of the prostate. Int J Cancer\u20082003;106:382\u20137.","DOI":"10.1002\/ijc.11227"},{"key":"2024010416382181000_BIB18","doi-asserted-by":"crossref","unstructured":"Kang GH, Lee S, Lee HJ, Hwang KS. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. J Pathol\u20082004;202:233\u201340.","DOI":"10.1002\/path.1503"},{"key":"2024010416382181000_BIB19","doi-asserted-by":"crossref","unstructured":"Jero\u0301nimo C, Henrique R, Hoque MO, et al. Quantitative RAR\u03b22 hypermethylation: a promising prostate cancer marker. Clin Cancer Res\u20082004;10:4010\u20134.","DOI":"10.1158\/1078-0432.CCR-03-0643"},{"key":"2024010416382181000_BIB20","doi-asserted-by":"crossref","unstructured":"Jeronimo C, Henrique R, Hoque MO, et al. A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res\u20082004;10:8472\u20138.","DOI":"10.1158\/1078-0432.CCR-04-0894"},{"key":"2024010416382181000_BIB21","doi-asserted-by":"crossref","unstructured":"Henrique R, Jeronimo C. Molecular detection of prostate cancer: a role for GSTP1 hypermethylation. Eur Urol\u20082004;46:660\u20139.","DOI":"10.1016\/j.eururo.2004.06.014"},{"key":"2024010416382181000_BIB22","doi-asserted-by":"crossref","unstructured":"Woodson K, Gillespie J, Hanson J, et al. Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens. Prostate\u20082004;60:25\u201331.","DOI":"10.1002\/pros.20013"},{"key":"2024010416382181000_BIB23","unstructured":"Jero\u0301nimo C, Varzim G, Henrique R, et al. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Cancer Epidemiol Biomarkers Prev\u20082002;11:445\u201350."},{"key":"2024010416382181000_BIB24","doi-asserted-by":"crossref","unstructured":"Nakayama M, Bennett CJ, Hicks J, et al. Hypermethylation of the human glutathione S-transferase \u03c0 gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate. Am J Pathol\u20082003;163:923\u201333.","DOI":"10.1016\/S0002-9440(10)63452-9"},{"key":"2024010416382181000_BIB25","unstructured":"Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res\u20081998;58:4515\u20138."},{"key":"2024010416382181000_BIB26","doi-asserted-by":"crossref","unstructured":"Jero\u0301nimo C, Usadel H, Henrique R, et al. Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer. Urology\u20082002;60:1131\u20135.","DOI":"10.1016\/S0090-4295(02)01949-0"},{"key":"2024010416382181000_BIB27","doi-asserted-by":"crossref","unstructured":"Eads CA, Danenberg KD, Kawakami K, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res\u20082000;28:E32.","DOI":"10.1093\/nar\/28.8.e32"},{"key":"2024010416382181000_BIB28","doi-asserted-by":"crossref","unstructured":"Clark SJ. Studying mammalian DNA methylation: bisulfite modification. In: Esteller M, editor. DNA methylation. Approaches, methods and applications. Boca Raton: CRC Press; 2004. p. 60.","DOI":"10.1201\/9780203487013.ch4"},{"key":"2024010416382181000_BIB29","doi-asserted-by":"crossref","unstructured":"Kovi J, Jackson MA, Heshmat MY. Ductal spread in prostatic carcinoma. Cancer\u20081985;56:1566\u201373.","DOI":"10.1002\/1097-0142(19851001)56:7<1566::AID-CNCR2820560717>3.0.CO;2-Y"},{"key":"2024010416382181000_BIB30","unstructured":"Epstein JI. Prostatic intraepithelial neoplasia. In: Epstein JI, editor. Prostate biopsy interpretation. Philadelphia: Lippincott-Raven; 1995. p. 45."},{"key":"2024010416382181000_BIB31","doi-asserted-by":"crossref","unstructured":"Waki T, Tamura G, Sato M, Motoyama T. Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene\u20082003;22:4128\u201333.","DOI":"10.1038\/sj.onc.1206651"},{"key":"2024010416382181000_BIB32","unstructured":"Troncoso P, Babaian RJ, Ro JY, Grignon DJ, von Eschenbach AC, Ayala AG. Prostatic intraepithelial neoplasia and invasive prostatic adenocarcinoma in cystoprostatectomy specimens. Urology\u20081989;34:52\u20136."},{"key":"2024010416382181000_BIB33","doi-asserted-by":"crossref","unstructured":"Harden SV, Sanderson H, Goodman SN, et al. Quantitative GSTP1 methylation improves the detection of prostate adenocarcinoma in sextant biopsies. J Natl Cancer Inst\u20082003;95:1634\u20137.","DOI":"10.1093\/jnci\/djg082"},{"key":"2024010416382181000_BIB34","doi-asserted-by":"crossref","unstructured":"Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med\u20082003;349:366\u201381.","DOI":"10.1056\/NEJMra021562"},{"key":"2024010416382181000_BIB35","doi-asserted-by":"crossref","unstructured":"Hermanek P, Hutter RVP, Sobin LH, Wagner G, Wittekind C. Prostate. In: Hermanek P, Hutter RVP, Sobin LH, Wagner G, Wittekind C, editors. Illustrated guide to the TNM\/pTNM classification of malignant tumors. Heidelberg (Germany): Springer-Verlag; 1997. p. 278\u201380.","DOI":"10.1007\/978-3-662-03432-3"},{"key":"2024010416382181000_BIB36","doi-asserted-by":"crossref","unstructured":"Gleason DF, Mellinger GT; Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histologic grading and clinical staging. J Urol\u20081974;111:58\u201364.","DOI":"10.1016\/S0022-5347(17)59889-4"},{"key":"2024010416382181000_BIB37","unstructured":"Drago JR, Mostofi FK, Lee F. Introductory remarks and workshop summary. Urology\u20081992;39:2\u20138."},{"key":"2024010416382181000_BIB38","doi-asserted-by":"crossref","unstructured":"Epstein JI, Grignon DJ, Humphrey PA, et al. Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol\u20081995;19:873\u201386.","DOI":"10.1097\/00000478-199508000-00002"},{"key":"2024010416382181000_BIB39","doi-asserted-by":"crossref","unstructured":"Olek A, Oswald J, Walter JA. A modified and improved method of bisulfite based cytosine methylation analysis. Nucleic Acids Res\u20081996;24:5064\u20136.","DOI":"10.1093\/nar\/24.24.5064"},{"key":"2024010416382181000_BIB40","unstructured":"Usadel H, Brabender J, Danenberg KD, et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res\u20082002;62:371\u20135."},{"key":"2024010416382181000_BIB41","doi-asserted-by":"crossref","unstructured":"Harden SV, Guo Z, Epstein JI, Sidransky D. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma. J Urol\u20082003;169:1138\u201342.","DOI":"10.1097\/01.ju.0000049627.90307.4d"},{"key":"2024010416382181000_BIB42","doi-asserted-by":"crossref","unstructured":"Henrique R, Jero\u0301nimo C, Hoque MO, et al. Frequent 14-3-3\u03c3 promoter methylation in benign and malignant prostate lesions. DNA Cell Biol\u20082005;24:264\u20139.","DOI":"10.1089\/dna.2005.24.264"}],"container-title":["Molecular Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/mcr\/article-pdf\/4\/1\/1\/3398347\/1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/mcr\/article-pdf\/4\/1\/1\/3398347\/1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T16:38:40Z","timestamp":1704386320000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/mcr\/article\/4\/1\/1\/284686\/Epigenetic-Heterogeneity-of-High-Grade-Prostatic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,30]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2006,1,30]]},"published-print":{"date-parts":[[2006,1,30]]}},"URL":"https:\/\/doi.org\/10.1158\/1541-7786.mcr-05-0113","relation":{},"ISSN":["1541-7786","1557-3125"],"issn-type":[{"value":"1541-7786","type":"print"},{"value":"1557-3125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,30]]}}}